Sugimoto R - Search Results

1

Clinical significance of serum RCAS1 levels detected by monoclonal antibody 22-1-1 in patients with cholangiocellular carcinoma.

Watanabe H, Enjoji M, Nakashima M, Noguchi K, Kinukawa N, Sugimoto R, Kotoh K, Nakamuta M, Nawata H, Watanabe T. Watanabe H, et al. Among authors: sugimoto r. J Hepatol. 2003 Oct;39(4):559-63. doi: 10.1016/s0168-8278(03)00363-5. J Hepatol. 2003. PMID: 12971966

2

Role of Rho small GTP binding protein in the regulation of actin cytoskeleton in hepatic stellate cells.

Kato M, Iwamoto H, Higashi N, Sugimoto R, Uchimura K, Tada S, Sakai H, Nakamuta M, Nawata H. Kato M, et al. Among authors: sugimoto r. J Hepatol. 1999 Jul;31(1):91-9. doi: 10.1016/s0168-8278(99)80168-8. J Hepatol. 1999. PMID: 10424288

3

Platelet-derived growth factor receptor tyrosine kinase inhibitor AG1295 attenuates rat hepatic stellate cell growth.

Iwamoto H, Nakamuta M, Tada S, Sugimoto R, Enjoji M, Nawata H. Iwamoto H, et al. Among authors: sugimoto r. J Lab Clin Med. 2000 May;135(5):406-12. doi: 10.1067/mlc.2000.105974. J Lab Clin Med. 2000. PMID: 10811056

4

A p160ROCK-specific inhibitor, Y-27632, attenuates rat hepatic stellate cell growth.

Iwamoto H, Nakamuta M, Tada S, Sugimoto R, Enjoji M, Nawata H. Iwamoto H, et al. Among authors: sugimoto r. J Hepatol. 2000 May;32(5):762-70. doi: 10.1016/s0168-8278(00)80245-7. J Hepatol. 2000. PMID: 10845663

5

Selenoorganic compound, ebselen, inhibits nitric oxide and tumor necrosis factor-alpha production by the modulation of jun-N-terminal kinase and the NF-kappab signaling pathway in rat Kupffer cells.

Shimohashi N, Nakamuta M, Uchimura K, Sugimoto R, Iwamoto H, Enjoji M, Nawata H. Shimohashi N, et al. Among authors: sugimoto r. J Cell Biochem. 2000 Jun 12;78(4):595-606. J Cell Biochem. 2000. PMID: 10861857

6

Activation of retinoic X receptor and peroxisome proliferator-activated receptor-gamma inhibits nitric oxide and tumor necrosis factor-alpha production in rat Kupffer cells.

Uchimura K, Nakamuta M, Enjoji M, Irie T, Sugimoto R, Muta T, Iwamoto H, Nawata H. Uchimura K, et al. Among authors: sugimoto r. Hepatology. 2001 Jan;33(1):91-9. doi: 10.1053/jhep.2001.21145. Hepatology. 2001. PMID: 11124825

7

Beta-lipoproteins influence the serum level of hepatitis C virus.

Enjoji M, Nakamuta M, Kinukawa N, Sugimoto R, Noguchi K, Tsuruta S, Iwao M, Kotoh K, Iwamoto H, Nawata H. Enjoji M, et al. Among authors: sugimoto r. Med Sci Monit. 2000 Sep-Oct;6(5):841-4. Med Sci Monit. 2000. PMID: 11208419

8

Analysis of HBs antigen negative variant of hepatitis B virus: unique substitutions, Glu129 to Asp and Gly145 to Ala in the surface antigen gene.

Koyanagi T, Nakamuta M, Sakai H, Sugimoto R, Enjoji M, Koto K, Iwamoto H, Kumazawa T, Mukaide M, Nawata H. Koyanagi T, et al. Among authors: sugimoto r. Med Sci Monit. 2000 Nov-Dec;6(6):1165-9. Med Sci Monit. 2000. PMID: 11208474

9

Serum levels of HCV RNA and core protein before and after incubation at 37 degrees C for 24 h.

Nakamuta M, Shimohashi N, Tada S, Kinukawa N, Enjoji M, Uchimura K, Motomura K, Sugimoto R, Kato M, Iwamoto H, Kuniyoshi M, Sakai H, Nawata H. Nakamuta M, et al. Among authors: sugimoto r. Hepatol Res. 2001 Mar 26;19(3):254-262. doi: 10.1016/s1386-6346(00)00115-7. Hepatol Res. 2001. PMID: 11251308

10

Serum leptin levels in patients with nonalcoholic chronic liver disease.

Nakamuta M, Tada S, Uchimura K, Enjoji M, Kinukawa N, Iwamoto H, Sugimoto R, Shimada M, Ohashi M, Sugimachi K, Nawata H. Nakamuta M, et al. Among authors: sugimoto r. Hepatogastroenterology. 2001 Mar-Apr;48(38):527-32. Hepatogastroenterology. 2001. PMID: 11379347

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

384 results

Search Page

Filters